ocrelizumabinfo.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * SITEMAP: | ||
Meta Tags
| Title | Our Commitment to Safety | OCREVUS® (ocrelizumab) US Healthcare |
| Description | Learn about OCREVUS® (ocrelizumab) periodic safety updates from ongoing clinical trials and post-marketing |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.18.10.87 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
ocrelizumabinfo.com Valuation
|
US$4,053,326
Last updated: 2023-05-12 16:34:15
ocrelizumabinfo.com has Semrush global rank of 2,611,264. ocrelizumabinfo.com has an estimated worth of US$ 4,053,326, based on its estimated Ads revenue. ocrelizumabinfo.com receives approximately 467,692 unique visitors each day. Its web server is located in United States, with IP address 104.18.10.87. According to SiteAdvisor, ocrelizumabinfo.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,053,326 |
| Daily Ads Revenue | US$3,742 |
| Monthly Ads Revenue | US$112,246 |
| Yearly Ads Revenue | US$1,346,952 |
| Daily Unique Visitors | 31,180 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ocrelizumabinfo.com. | A | 299 | IP: 104.18.10.87 |
| ocrelizumabinfo.com. | A | 299 | IP: 104.18.11.87 |
| ocrelizumabinfo.com. | AAAA | 299 | IPV6: 2606:4700::6812:b57 |
| ocrelizumabinfo.com. | AAAA | 299 | IPV6: 2606:4700::6812:a57 |
| ocrelizumabinfo.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
| ocrelizumabinfo.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
| ocrelizumabinfo.com. | TXT | 300 | TXT Record: 9dy2phksrqtcgb02dvvm6j9p6g8f2tcl |
| ocrelizumabinfo.com. | TXT | 300 | TXT Record: v=spf1 -all |
HtmlToTextCheckTime:2023-05-12 16:34:15
| FAQ FAQ Glossary Glossary Prescribing Information Prescribing Information MENU FAQ Glossary Prescribing Information Our Commitment to Safety Communication Verified safety updates from ongoing ocrelizumab clinical trials and post-marketing experience The Prescribing Information is the primary source of information on the known and potential risks of ocrelizumab for relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS). As of March 2022, more than 250,000 patients with RMS and PPMS have started ocrelizumab globally , amounting to a total of more than 535,000 patient-years. 1 >9500 patients in clinical trials and open-label extension >250,000 patients with post-marketing experience The following ocrelizumab global safety updates are available. Click below to learn more: Updated Safety Analysis Learn more Safety Topics Learn more Post-marketing Commitments Learn more Indication: Ocrelizumab is indicated for the treatment of: Relapsing forms of |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sun, 19 Dec 2021 15:46:57 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Sun, 19 Dec 2021 16:46:57 GMT Location: https://ocrelizumabinfo.com/ Set-Cookie: __cfruid=683be0a6de7a44d5ba3f02f07cc0c7f692c0d2b2-1639928817; path=/; domain=.ocrelizumabinfo.com; HttpOnly Server: cloudflare CF-RAY: 6c01c44719aa195d-EWR HTTP/2 301 date: Sun, 19 Dec 2021 15:46:58 GMT content-type: text/html; charset=iso-8859-1 location: https://www.ocrelizumabinfo.com/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=0f6f77720d45861283dc16e23117b1babec7ef4e-1639928818; path=/; domain=.ocrelizumabinfo.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6c01c4476b3f32fa-EWR HTTP/2 200 date: Sun, 19 Dec 2021 15:46:58 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=0f6f77720d45861283dc16e23117b1babec7ef4e-1639928818; path=/; domain=.ocrelizumabinfo.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6c01c44a0e05f059-EWR |
ocrelizumabinfo.com Whois Information
Domain Name: OCRELIZUMABINFO.COM Registry Domain ID: 2193996143_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2021-12-01T04:01:55Z Creation Date: 2017-11-30T10:36:01Z Registry Expiry Date: 2023-11-30T10:36:01Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:47:52Z <<< |